Novel Visualization Methods Assisted Transurethral Resection for Bladder Cancer: An Updated Survival-Based Systematic Review and Meta-Analysis

Frontiers in Oncology

卷:11

Lingyun Zhou¹  Zhongkai Ma²  Honglin Li²  Pingchuan Ma²  Chunjie Li³  Wenbin Yang³  Yubin Cao⁴ 

[1] Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China;

[2] Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China;

[3] Department of Medical Affairs, West China Hospital of Stomatology, Sichuan University, Chengdu, China;

[4] Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China;

[5] State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, China;

关键词: narrow-band imaging;    photodynamic diagnosis;    hexylaminolaevulinate;    5-aminolaevulinic acid;    cystectomy;    cystoscopy;   

DOI  :  10.3389/fonc.2021.644341

来源: DOAJ

【 摘 要 】

BackgroundPhotodynamic diagnosis and narrow-band imaging could help improve the detection rate in transurethral resection (TUR) of bladder cancer. It remained controversial that the novel visualization method assisted transurethral resection (VA-TUR) could elongate patients’ survival compared to traditional TUR.MethodsWe performed electronic and manual searching until December 2020 to identify randomized controlled trials comparing VA-TUR with traditional TUR, which reported patients’ survival data. Two reviewers independently selected eligible studies, extracted data, assessed the risk of bias. Meta-analysis was conducted according to subgroups of types of visualization methods (A) and clinical stage of participants. Publication bias was detected.ResultsWe included 20 studies (reported in 28 articles) in this review. A total of 6,062 participants were randomized, and 5,217 participants were included in the analysis. Only two studies were assessed at low risk of bias. VA-TURB could significantly improve the recurrence-free survival (RFS) (HR = 0.72, 95% CI: 0.66 to 0.79, P <0.00001, I2 = 42%) and progression-free survival (PFS) (HR = 0.62, 95% CI: 0.46 to 0.82, P <0.0008, I2 = 0%) compared with TUR under white light. The results remain stable whatever the type of visualization method. The difference could be observed in the non-muscle-invasive bladder cancer (NMIBC) population (P <0.05) but not in the mixed population with muscle-invasive bladder cancer (MIBC) participants (P >0.05).ConclusionVA-TUR could improve RFS and PFS in NMIBC patients. No significant difference is found among different types of VA-TUR. VA-TUR may be not indicated to MIBC patients.

【 授权许可】

Unknown